The Netherlands.
J Cataract Refract Surg. 2024 Oct 1;50(10):1094-1098. doi: 10.1097/j.jcrs.0000000000001529.
In May 2023, a 36-year-old carpenter complained of a sudden decrease in visual acuity in both eyes after his fourth COVID-19 vaccination. He underwent extensive evaluation by ophthalmological, neurological, and internal medicine specialists elsewhere, which was unremarkable, except for a computed tomography scan of his brain showing minor occipital calcifications. In 2021, he had been diagnosed with anterior basement membrane dystrophy and treated with phototherapeutic keratectomy (PTK) of the left eye, leading to significant postoperative haze. On referral in July 2023, slitlamp examination showed significant anterior basement membrane dystrophy in the right eye, whereas the left eye had an extensive central scar in the anterior stroma, measuring up to 6 mm in width and 140 µm in depth (Figures 1-3JOURNAL/jcrs/04.03/02158034-202410000-00017/figure1/v/2024-09-18T130724Z/r/image-tiffJOURNAL/jcrs/04.03/02158034-202410000-00017/figure2/v/2024-09-18T130724Z/r/image-tiffJOURNAL/jcrs/04.03/02158034-202410000-00017/figure3/v/2024-09-18T130724Z/r/image-tiff). His corrected distance visual acuity was 20/80 in his right eye and 20/200 in his left eye, with a manifest refraction of -0.50 -3.75 × 170 and +0.00 -4.75 × 180, respectively. Corneal Scheimpflug topography showed regular corneal astigmatism of 3.3 diopters (D) and 5.5 D in the right and left eyes, respectively, with a corneal thickness of 550 and 566 µm (Figure 4JOURNAL/jcrs/04.03/02158034-202410000-00017/figure4/v/2024-09-18T130724Z/r/image-tiff). The Schirmer tear test was 20-20 mm. Fundoscopy, electrophysiological testing, and retinal optical coherence tomography (OCT) showed no abnormalities. The patient mentioned he had Crohn disease, managed with ustekinumab (a monoclonal antibody inhibitor of cytokines interleukin [IL]-12 and IL-23), but he had discontinued it because of the apparent remission of the disease. Attempts to improve visual acuity involved a soft bandage contact lens in the right eye, which was discontinued after 2 days because of the occurrence of a small corneal infiltrate that healed with a short course of topical antibiotics. Unfortunately, because of his vision, he cannot perform his tasks as a carpenter anymore. Which is your recommended treatment for both eyes?
2023 年 5 月,一名 36 岁的木匠在第四次接种 COVID-19 疫苗后突然出现双眼视力下降,前来就诊。他在其他地方接受了眼科、神经科和内科专家的广泛评估,除了大脑的计算机断层扫描显示枕部有轻微钙化外,其他结果均无明显异常。2021 年,他被诊断为前基底膜营养不良,并接受左眼光动力角膜切除术(PTK)治疗,导致术后明显混浊。2023 年 7 月转诊时,裂隙灯检查显示右眼有明显的前基底膜营养不良,而左眼前部基质中有广泛的中央瘢痕,宽度达 6 毫米,深度达 140 微米(图 1-3)。他的右眼矫正视力为 20/80,左眼为 20/200,右眼的显影为 -0.50-3.75×170,左眼为 +0.00-4.75×180。角膜 Scheimpflug 地形图显示右眼和左眼的角膜散光分别为 3.3 屈光度(D)和 5.5 D,角膜厚度分别为 550 和 566 微米(图 4)。Schirmer 泪液测试为 20-20mm。眼底检查、电生理检查和视网膜光学相干断层扫描(OCT)均未见异常。患者提到他患有克罗恩病,接受乌司奴单抗(一种细胞因子白细胞介素[IL]-12 和 IL-23 的单克隆抗体抑制剂)治疗,但由于疾病明显缓解而停止了治疗。提高视力的尝试包括右眼软性绷带接触镜,但由于发生小角膜浸润,仅使用 2 天就停用了,浸润经短期局部抗生素治疗后愈合。不幸的是,由于视力问题,他再也无法从事木匠工作了。您建议对双眼进行何种治疗?